L463 (Chlorpheniramine maleate 4 mg)
Pill imprint L463 has been identified as Chlorpheniramine maleate 4 mg.
Chlorpheniramine is used in the treatment of urticaria; allergic rhinitis; cold symptoms; allergic reactions and belongs to the drug class antihistamines. There is no proven risk in humans during pregnancy. Chlorpheniramine 4 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 4 mg
- Rx and/or OTC
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- HyVee Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
More about chlorpheniramine
- Chlorpheniramine controlled-release capsules
- Chlorpheniramine suspension
- Chlorpheniramine suspension drops
- Chlorpheniramine sustained-release capsules
- Chlorpheniramine syrup
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.